Protein fingerprints may spot kidney rejection faster
NCT ID NCT04851145
First seen May 26, 2026 · Last updated Jun 11, 2026 · Updated 4 times
Summary
This study looked at whether analyzing proteins in kidney biopsy samples can better detect early signs of rejection after a transplant. Researchers studied 141 kidney transplant recipients to see if a protein signature could identify microvascular inflammation, a key sign of antibody-mediated rejection. The goal is to make diagnosis more accurate and consistent than current methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT REJECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital Edouard Herriot
Lyon, 69003, France
-
Hôpital Necker
Paris, 75015, France
-
Hôpital Pellegrin
Bordeaux, 33000, France
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.